Pharmacovigilance На русский

News

Petrovax Pharm President Elena Arkhangelskaya quits
Petrovax Pharm President Elena Arkhangelskaya quits
Petrovax Pharm President Elena Arkhangelskaya quits
25.04.2018
Vaccination: prevention of dangerous diseases and contribution to nation's health
Vaccination: prevention of dangerous diseases and...
Vaccination: prevention of dangerous diseases and contribution to nation's health
24.04.2018
Norilsk hosted an interactive workshop on preventive vaccination against infectious diseases
Norilsk hosted an interactive workshop on preventive...
Norilsk hosted an interactive workshop on preventive vaccination against infectious diseases
16.04.2018
Boehringer Ingelheim, Petrovax Pharm, and Interros Group on stroke prevention and management
Boehringer Ingelheim, Petrovax Pharm, and Interros Group on...
Boehringer Ingelheim, Petrovax Pharm, and Interros Group on stroke prevention and management
21.03.2018
State Duma Deputy Vyacheslav Fetisov visits Petrovax Pharm facility
State Duma Deputy Vyacheslav Fetisov visits Petrovax Pharm...
State Duma Deputy Vyacheslav Fetisov visits Petrovax Pharm facility
27.02.2018
Petrovax Pharm President Elena Arkhangelskaya is among TOP5 most influential pharma executives
Petrovax Pharm President Elena Arkhangelskaya is among TOP5...
Petrovax Pharm President Elena Arkhangelskaya is among TOP5 most influential pharma executives
22.02.2018
The Russians received better access to acute ischemic stroke therapy
The Russians received better access to acute ischemic...
The Russians received better access to acute ischemic stroke therapy
15.02.2018
Petrovax Pharm pick up RUIE award “For the Dynamic Development of Business”
Petrovax Pharm pick up RUIE award “For the Dynamic...
Petrovax Pharm pick up RUIE award “For the Dynamic Development of Business”
09.02.2018
Petrovax Pharm wins All-Russia Contest
Petrovax Pharm wins All-Russia Contest "Russian...
Petrovax Pharm wins All-Russia Contest "Russian Business Leaders: Performance and Commitment’ 2017"
19.01.2018
Flu vaccination coverage of Moscow region population to grow due to Grippol® plus
Flu vaccination coverage of Moscow region population to...
Flu vaccination coverage of Moscow region population to grow due to Grippol® plus
30.11.2017
Physicians consider Polyoxidonium® the best medication for ARVI and flu treatment and prevention in children
Physicians consider Polyoxidonium® the best medication for...
Physicians consider Polyoxidonium® the best medication for ARVI and flu treatment and prevention in children
24.11.2017
EU PASS findings on Russian originator product Polyoxidonium® reported at an international conference
EU PASS findings on Russian originator product...
EU PASS findings on Russian originator product Polyoxidonium® reported at an international conference
21.11.2017
12 November is the World Pneumonia Day
12 November is the World Pneumonia Day
12 November is the World Pneumonia Day
09.11.2017
Petrovax Pharm at CPhI Worldwide Exhibition in Frankfurt on the Main
Petrovax Pharm at CPhI Worldwide Exhibition in Frankfurt on...
Petrovax Pharm at CPhI Worldwide Exhibition in Frankfurt on the Main
31.10.2017
Petrovax Pharm successfully certified for ISO 9001:2015 conformity
Petrovax Pharm successfully certified for ISO 9001:2015...
Petrovax Pharm successfully certified for ISO 9001:2015 conformity
18.10.2017
Innovative thrombolytics for acute myocardial infarction readily accessible for Russian patients
Innovative thrombolytics for acute myocardial infarction...
Innovative thrombolytics for acute myocardial infarction readily accessible for Russian patients
10.10.2017
Large-scale Grippol® plus immunization launched in Belarus
Large-scale Grippol® plus immunization launched in Belarus
Large-scale Grippol® plus immunization launched in Belarus
03.10.2017
Russian and Kazakhstan experts: influenza remains a serious healthcare challenge
Russian and Kazakhstan experts: influenza remains a serious...
Russian and Kazakhstan experts: influenza remains a serious healthcare challenge
25.09.2017
Petrovax Pharm reports on achievements in development and use of original Russian influenza vaccines at conference “Trends in Influenza Research 2017”
Petrovax Pharm reports on achievements in development and...
Petrovax Pharm reports on achievements in development and use of original Russian influenza vaccines at conference “Trends in Influenza Research 2017”
21.09.2017
Clinical trial results of first Russian quadrivalent influenza vaccine presented at the Sixth ESWI Influenza Conference
Clinical trial results of first Russian quadrivalent...
Clinical trial results of first Russian quadrivalent influenza vaccine presented at the Sixth ESWI Influenza Conference
14.09.2017